Delivery Order 36C25022D0022-36C25022N0212
- Not listed
- This is a federal delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 10 to Biofire Diagnostics LLC, a biotech company that specializes in infectious disease testing. The delivery order, valued at $550,736.25, is for the provision of Biofire reagents and has a completion date of December 31, 2025. This award is part of a larger indefinite delivery contract established between VISN 10 and Biofire Diagnostics to facilitate ongoing...
- This federal contract award was made by the Veterans Integrated Service Network (VISN) 23 of the Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $92,880 Firm Fixed Price contract is a Blanket Purchase Agreement (BPA) call order under Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract is for the provision of virus,...
- This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The award, valued at $1,598,542.00, is for molecular pathogen detection products and services. The contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its Veterans Integrated Service Network (VISN) 8. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration...
- This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $118,609.78 delivery order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 for BioFire equipment. The contract is under Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests, and is a firm fixed-price contract with no set-aside...
- This federal contract award was issued by the Veterans Integrated Service Network (VISN) 10 of the Department of Veterans Affairs (VA) to Biofire Diagnostics LLC. The $76,972.20 fixed-price delivery order was placed against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract is for the provision of 30-pouch respiratory panel test kits, with a delivery date of May 28, 2020. The contract did not...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services. The contract, valued at $810,091.80, was awarded by the Veterans Health Administration (VHA) of the Department of Veterans Affairs (VA) under the VA's Veterans Integrated Service Network (VISN) 8. The contract is a BPA (Blanket Purchase Agreement) call against Biofire's General Services Administration (GSA) Federal Supply...
- This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract, valued at $798,120.00, is for MOLECULAR PATHOGEN DETECTION services and was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) through its Veterans Integrated Service Network (VISN) 8. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply...
- This is a federal contract award from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The $1,050,268.75 contract is for the provision of Biofire reagents and test kits, which are used for rapid pathogen identification. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply Schedule...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company, was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 10. The $87,232.50 firm-fixed-price delivery order contract is for the provision of specialized diagnostic testing panels, reagents, and associated services. The contract has an ultimate completion date of January 16, 2024 and was awarded on November 30, 2021. Biofire Diagnostics is an experienced federal...
- This federal contract award was issued by the Veterans Integrated Service Network 6 (VISN 6) of the Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The $80,544 firm-fixed-price contract is for the provision of FilmArray diagnostic testing services. The contract was awarded against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics,...
- 36C25022D0022Indefinite Delivery Contract
- 36C25022D0022-36C25022N0212Delivery Order
This federal contract award was issued by the Veterans Integrated Service Network (VISN) 10, a component of the Department of Veterans Affairs (VA) Veterans Health Administration (VHA), to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $238,705.35 firm-fixed-price delivery order contract is for the provision of Biofire reagents and runs through December 31, 2026. This award is part of a larger indefinite delivery contract between Biofire Diagnostics and VISN 10 to provide these products on an as-needed basis. Biofire Diagnostics has also received similar awards from other VHA VISNs as well as the Indian Health Service for its diagnostics capabilities. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($311k) | 4/3/25 | |
| P00001 | Other Administrative Action | ($880) | 6/28/22 | |
| Not listed | Not listed | $550.7k | 12/23/21 |